a multi centre randomised placebo-controlled double-blind clinical trial for the evaluation of efficacy of specific immunotherapy with an aluminium hydroxide-adsorbed recombinant hypoallergenic derivative of the major birch pollen allergen r Bet v1-FV on
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/06/2010 - 30/04/2014